reverSASP Therapeutics
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- Undisclosed
Investors
- 2
About reverSASP Therapeutics
a. reverSASP Therapeutics is a bio-venture company that develops new drugs for aging-related diseases based on advanced science related to senescent cell research., Ltd. The company develops a drug discovery pipeline for aging-related diseases by elucidating the properties of inflammatory senescent cells that are the root causes of numerous age-related diseases.
Who invested in reverSASP Therapeutics
2 investors across 1 round
See all investors in reverSASP Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 7, 2022
Amount
Undisclosed
Investors
Questions about reverSASP Therapeutics
Who invested in reverSASP Therapeutics?
reverSASP Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has reverSASP Therapeutics raised?
reverSASP Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did reverSASP Therapeutics last raise money?
reverSASP Therapeutics's most recent round on record is a Seed, in Jul 2022.
What does reverSASP Therapeutics do?
reverSASP Therapeutics is a biotechnology company.
Where is reverSASP Therapeutics headquartered?
reverSASP Therapeutics is headquartered in Tokyo, Japan.
Which VCs invest in companies like reverSASP Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at reverSASP Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like reverSASP Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.